3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      In vivo evaluation of drug-drug interactions linked to UGT inhibition: the effect of probenecid on dalcetrapib pharmacokinetics.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To assess the effect of the UGT inhibitor probenecid on the pharmacokinetics of dalcetrapib, an investigational drug whose pharmacologically active thiol form undergoes glucuronidation (fm UGT ≥ 0.25).

          Related collections

          Author and article information

          Journal
          Int J Clin Pharmacol Ther
          International journal of clinical pharmacology and therapeutics
          Dustri-Verlgag Dr. Karl Feistle
          0946-1965
          0946-1965
          Mar 2013
          : 51
          : 3
          Affiliations
          [1 ] Roche Products Ltd, UK.
          Article
          10395
          10.5414/CP201766
          23357838
          0eeefb77-e224-430f-a644-7bd0cca9dc4d
          History

          Comments

          Comment on this article